Millions of people worldwide are affected by Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Yet the causes, diagnostic markers, progression, and FDA-approved treatments remain unknown. The shared vision of the ME/CFS Collaborative Research Network (ME/CFSnet) is to encourage collaborative research in partnership with individuals and advocacy groups to understand the disease and develop better diagnosis and treatment.
ICanCME Canadian Collaborative Conference on ME
October 29, 2025
Mark your calendars for the ICanCME Canadian Collaborative Conference on ME: Nothing About Us Without Us. This virtual 3-day event is free to attend: November 4-6. Register today!
Take Me There2025 IACFS Conference
September 10, 2025
Mark your calendars for the International Association for IACFS/ME Virtual Research and Medical Conference from October 22-25. Register today!
Take Me ThereNew Publication! New Study Examines Immune Response in ME/CFS Pre/Post Exercise
September 3, 2025
New research from MECFSnet investigators at Columbia's Center for Solutions for ME/CFS finds heightened innate immunity may trigger chronic inflammation, fatigue, and post-exertional malaise in MECFS. This study was published in npj Metabolic Health and Disease.
Take Me ThereThese institutions are working together as the ME/CFS Research Network.
Visit the CDC to learn more about ME/CFS.
Investigators, health care providers, and advocates are collaborating across the Research Network to drive progress in understanding ME/CFS. Together, we can advance discoveries to improve the lives of members of the ME/CFS community.
What is ME/CFS?
Myalgic Encephalomyelitis (ME), also referred to as Chronic Fatigue Syndrome (CFS), is a multi-system disease that causes dysfunction of the neurological, immune, endocrine, and energy metabolism systems.